Heba F. Salem

IL4I1 Is a Metabolic Immune Checkpoint that Activates the AHR and Promotes Tumor Progression

Ahmed Sadik, Luis F. Somarribas Patterson, Selcen Öztürk et al. · Cell · 2020 · 576 citations · Full text

Medicine, Immunology, Oncology +16

5-Fluorouracil shell-enriched solid lipid nanoparticles (SLN) for effective skin carcinoma treatment

Rasha A. Khallaf, Heba F. Salem, Ahmed Abdelbary · Drug Delivery · 2016 · 109 citations

Pharmacy, Pharmaceutics, Pharmacology +17

Nanosized Transferosome-Based Intranasal In Situ Gel for Brain Targeting of Resveratrol: Formulation, Optimization, In Vitro Evaluation, and In Vivo Pharmacokinetic Study

Heba F. Salem, Rasha M. Kharshoum, Heba A. Abou‐Taleb et al. · AAPS PharmSciTech · 2019 · 93 citations

Pharmacy, Pharmaceutics, Pharmacology +17

<i>In vitro</i>/<i>in vivo</i> evaluation of an optimized fast dissolving oral film containing olanzapine co-amorphous dispersion with selected carboxylic acids

Eman Maher, Ahmed Mahmoud Abdelhaleem Ali, Heba F. Salem et al. · Drug Delivery · 2016 · 92 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

Evaluation and optimization of pH-responsive niosomes as a carrier for efficient treatment of breast cancer

Heba F. Salem, Rasha M. Kharshoum, Fatma I. Abo El‐Ela et al. · Drug Delivery and Translational Research · 2018 · 86 citations

Pharmacy, Molecular Pharmaceutics, Oncology +16